Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial.

BACKGROUND The aim was to study whether prolongation of luteal support during early pregnancy influences the delivery rate after IVF. METHODS Dual centre study including 303 women who achieved pregnancy after IVF or ICSI was used. All were treated with the long protocol using GnRH agonists and given luteal support with 200 mg vaginal progesterone three times daily during 14 days from the day of transfer until the day of a positive HCG test. The study group (n = 150) withdrew vaginal progesterone from the day of positive HCG. The control group (n = 153) continued administration of vaginal progesterone during the next 3 weeks of pregnancy. RESULTS The number of miscarriages prior to and after week 7 of gestation was seven (4.6%) and 15 (10.0%) in the study group and five (3.3%) and 13 (8.5%) in the control group respectively. The number of deliveries was 118 (78.7 %) in the study group and 126 (82.4 %) in the control group. The differences were not significant. CONCLUSIONS Prolongation of progesterone supplementation in early pregnancy has no influence on the miscarriage rate, and thus no effect on the delivery rate. Progesterone supplementation can safely be withdrawn at the time of a positive HCG test.

[1]  K. Diedrich,et al.  Evaluation of an optimal luteal phase support protocol in IVF , 2001, Acta obstetricia et gynecologica Scandinavica.

[2]  A. Loft,et al.  Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate. , 2001, Fertility and sterility.

[3]  P. Devroey,et al.  Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. , 2000, Human reproduction.

[4]  W. Schoolcraft,et al.  Experience with progesterone gel for luteal support in a highly successful IVF programme. , 2000, Human reproduction.

[5]  J. Olsen,et al.  The Danish in vitro fertilisation (IVF) register. , 1999, Danish medical bulletin.

[6]  L. Layman,et al.  Administration of progesterone before oocyte retrieval negatively affects the implantation rate. , 1999, Fertility and sterility.

[7]  B. V. Van Voorhis,et al.  Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation. , 1998, Fertility and sterility.

[8]  B. Mol,et al.  Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial. , 1996, Human reproduction.

[9]  M. Sauer,et al.  Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. , 1994, Fertility and sterility.

[10]  J. Leeton,et al.  Vaginal progesterone as luteal phase support in an IVF/GIFT programme. , 1992, European journal of obstetrics, gynecology, and reproductive biology.

[11]  D. Krebs,et al.  The effect of 17α-hydroxyprogesterone caproate/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: A prospective and randomized controlled trail , 1992 .

[12]  P. Devroey,et al.  A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. , 1992, Human reproduction.

[13]  P. Devroey,et al.  The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. , 1988, Human reproduction.

[14]  P. Devroey,et al.  The luteal phase after in-vitro fertilization and related procedures. , 1988, Human reproduction.